Zobrazeno 1 - 9
of 9
pro vyhledávání: '"O. P. Purohit"'
Autor:
Robert U. Ashford, Eugene V. McCloskey, O. Prakash Purohit, Christine E. Ingram, Robert J. Grimer, Robert E. Coleman
Publikováno v:
Sarcoma, Vol 6, Iss 4, Pp 131-133 (2002)
Patient: We report a 32-year-old women with a pelvic Ewing's sarcoma, who developed skeletal metastases within 20 months of diagnosis but following treatment remains disease-free at 10 years.
Externí odkaz:
https://doaj.org/article/1ec4e665cf274dfe9e6310d3115d6647
Autor:
John A. Kanis, O. P. Purohit, K. J. Quinn, K. Schlosser, C. Black, H. Huss, J. J. F. Vinholes, Robert E. Coleman
Publikováno v:
Annals of Oncology. 10:311-316
Summary Background Bisphosphonates are an important component of the treatment of metastatic bone disease but more potent, oral formulations are required to improve the effectiveness and convenience of treatment. An oral formulation of the new bispho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f015dfe5261ba71481390e355e924d9
https://doi.org/10.1023/a:1008386501738
https://doi.org/10.1023/a:1008386501738
Publikováno v:
Cancer. 80:1686-1690
Eighty-six patients with heavily pretreated progressive bone metastases (52 with breast carcinoma, 17 with prostate carcinoma, and 17 others) were included in 2 studies designed to assess the clinical and biochemical effects of a single 120 mg, 2-hou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab1ae885a0ea6e5c0bd2d3e84df42d87
https://doi.org/10.1002/(sici)1097-0142(19971015)80:8+<1686::aid-cncr20>3.0.co
https://doi.org/10.1002/(sici)1097-0142(19971015)80:8+<1686::aid-cncr20>3.0.co
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 12(10)
Summary Background: There is considerable debate as to the optimum schedule of bisphosphonat e treatment in advanced malignancy. Short term studies using symptomatic response and biochemical markers of bone resorption may provide useful insight into
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16d11aa52f73c76adf2607bb7c645b31
https://pubmed.ncbi.nlm.nih.gov/11762816
https://pubmed.ncbi.nlm.nih.gov/11762816
Publikováno v:
Cancer. 80
Eighty-six patients with heavily pretreated progressive bone metastases (52 with breast carcinoma, 17 with prostate carcinoma, and 17 others) were included in 2 studies designed to assess the clinical and biochemical effects of a single 120 mg, 2-hou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::09671c64e74e2b3c51cf5a1156c5cf8d
https://pubmed.ncbi.nlm.nih.gov/9362437
https://pubmed.ncbi.nlm.nih.gov/9362437
Publikováno v:
Indian journal of cancer. 14(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::caebd4163c8e6eda0d4a43f300498ed7
https://pubmed.ncbi.nlm.nih.gov/885576
https://pubmed.ncbi.nlm.nih.gov/885576
Publikováno v:
Indian journal of cancer. 15(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f08557f5c3b90479ee1cdb5c4c4c9081
https://pubmed.ncbi.nlm.nih.gov/750357
https://pubmed.ncbi.nlm.nih.gov/750357
Publikováno v:
Indian journal of pathologymicrobiology. 22(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3e2ccc2754fd3902604c7ac85611690f
https://pubmed.ncbi.nlm.nih.gov/489089
https://pubmed.ncbi.nlm.nih.gov/489089
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.